muscle loss glp-1 Sarcopenia in the era of receptor agonists: Implications for the internist GLP-1 therapies lead to weight

Work with your endocrinologist to determine appropriate testing frequency

BEST, PHD, Diabetes Care 34:9095, 2011 1 Summary of PharmacologicIncretin Actions on Different Target Tissues Heart Brain Neuroprotection Stomach Appetite Gastric Emptying Cardioprotection Cardiac Output GLP-1 _ Liver GI Tract Insulin Secretion -Cell Neogenesis -Cell Apoptosis Glucagon Secretion Glucose Production + Glucose Uptake Muscle Drucker DJ, Cell Metab

Warnings do not exceed the recommended daily dose

15(b), countries such as Somalia and Niger are far above the frontier line, indicating significant gaps from the theoretical minimum levels